Ajanta Pharma Schedules Meetings for Domestic Institutional Investors in Mumbai

Ajanta Pharma Schedules Meetings for Domestic Institutional Investors in Mumbai

Ajanta Pharma Schedules Meetings for Domestic Institutional Investors in Mumbai​

Ajanta Pharma Ltd has announced a schedule of meetings designated for institutional investors and analysts, providing details regarding upcoming one on one conferences hosted by the company.

The meeting is specifically targeted towards Domestic Institutional Investors (DII's). The event details have been structured to allow focused discussions between the company representatives and institutional participants.

Details regarding the scheduled investor meetings are presented below:

Date of ConferenceConference NameType of MeetingPlace
17th & 18th June 2026Domestic Institutional Investors (DII's)one on oneMumbai

The company noted that the scheduled meetings are subject to change, and any adjustments may be necessitated by exigencies on either side. The discussion during these sessions will be conducted strictly based on already published information.

AJANTPHARM Stock Price Movement​

Shares of Ajanta Pharma Limited settled lower today, shedding 0.21% as the stock closed at ₹3131. The equity traded within an intraday range spanning from a low of ₹3110 to a high of ₹3178, with 80,576 shares recorded in the post-market activity.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top